Home LiteratureArticle Details
PMID: 17301785 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Structural definition of a conserved neutralization epitope on HIV-1 gp120.

Nature ·Vol. 445 ·No. 7129 ·2007-02-15 ·Pages 732-7

Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD

Abstract

The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 A resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.

MeSH Terms
Binding Sites CD4 Antigens/chemistry,metabolism Conserved Sequence Epitopes/chemistry,immunology HIV Antibodies/immunology,pharmacology HIV Envelope Protein gp120/chemistry,immunology,metabolism HIV-1/chemistry,drug effects,immunology,physiology Models, Molecular Molecular Weight Neutralization Tests Protein Conformation
Chemicals
CD4 Antigens Epitopes HIV Antibodies HIV Envelope Protein gp120
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Zhou Tongqing
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Xu Ling
Dey Barna
Hessell Ann J
Van Ryk Donald
Xiang Shi-Hua
Yang Xinzhen
Zhang Mei-Yun
Zwick Michael B
Arthos James
Burton Dennis R
Dimitrov Dimiter S
Sodroski Joseph
Wyatt Richard
Nabel Gary J
Kwong Peter D
References (45)
45 references, click to expand
  1. Restraining the conformation of HIV-1 gp120 by removing a flexible loop.
    EMBO J. 2006 Oct 18;25(20):5026-35 PMID: 17006538
  2. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  3. Molecular recognition in antibody-antigen complexes.
    Adv Protein Chem. 2002;61:119-60 PMID: 12461823
  4. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Nature. 1998 Jun 18;393(6686):705-11 PMID: 9641684
  5. Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1.
    J Virol. 2004 Dec;78(23):12975-86 PMID: 15542649
  6. Structure of an unliganded simian immunodeficiency virus gp120 core.
    Nature. 2005 Feb 24;433(7028):834-41 PMID: 15729334
  7. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
    Science. 1987 Sep 11;237(4820):1351-5 PMID: 3629244
  8. Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies.
    J Biol Chem. 2002 Mar 29;277(13):11456-64 PMID: 11805109
  9. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.
    Science. 1994 Nov 11;266(5187):1024-7 PMID: 7973652
  10. Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization.
    Protein Sci. 1999 Aug;8(8):1696-701 PMID: 10452614
  11. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  12. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
    J Virol. 1996 Feb;70(2):1100-8 PMID: 8551569
  13. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density.
    J Struct Biol. 1999 Apr-May;125(2-3):156-65 PMID: 10222271
  14. Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1).
    J Biol Chem. 1999 Feb 12;274(7):4115-23 PMID: 9933605
  15. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
    Nat Struct Mol Biol. 2006 Aug;13(8):740-7 PMID: 16862157
  16. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
    Nature. 1985 Jul 4-10;316(6023):69-72 PMID: 2989706
  17. Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.
    J Virol. 2003 May;77(10):5863-76 PMID: 12719580
  18. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Nature. 2002 Dec 12;420(6916):678-82 PMID: 12478295
  19. Structure of a human common cold virus and functional relationship to other picornaviruses.
    Nature. 1985 Sep 12-18;317(6033):145-53 PMID: 2993920
  20. Antibodies, viruses and vaccines.
    Nat Rev Immunol. 2002 Sep;2(9):706-13 PMID: 12209139
  21. Crystallography & NMR system: A new software suite for macromolecular structure determination.
    Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 PMID: 9757107
  22. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
    J Virol. 2003 Jan;77(1):642-58 PMID: 12477867
  23. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.
    J Biol Chem. 2006 Jun 9;281(23):15829-36 PMID: 16597622
  24. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.
    J Immunol. 1990 Jun 15;144(12):4641-7 PMID: 1693639
  25. Processing of X-ray diffraction data collected in oscillation mode.
    Methods Enzymol. 1997;276:307-26 PMID: 27754618
  26. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
    Cell. 1986 Jun 6;45(5):637-48 PMID: 2423250
  27. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  28. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
    Science. 1998 Jun 19;280(5371):1884-8 PMID: 9632381
  29. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.
    Nature. 1981 Jan 29;289(5796):373-8 PMID: 6162101
  30. A trimeric structural domain of the HIV-1 transmembrane glycoprotein.
    Nat Struct Biol. 1995 Dec;2(12):1075-82 PMID: 8846219
  31. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Nature. 1998 Jun 18;393(6686):648-59 PMID: 9641677
  32. Specific chemical and structural damage to proteins produced by synchrotron radiation.
    Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):623-8 PMID: 10639129
  33. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
    J Virol. 1993 Jul;67(7):3978-88 PMID: 7685405
  34. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.
    J Virol. 2001 Sep;75(17):8340-7 PMID: 11483779
  35. Structural evidence for recognition of a single epitope by two distinct antibodies.
    Proteins. 2000 Sep 1;40(4):572-8 PMID: 10899782
  36. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
    AIDS. 1999;13 Suppl A:S137-62 PMID: 10885772
  37. Timing the ancestor of the HIV-1 pandemic strains.
    Science. 2000 Jun 9;288(5472):1789-96 PMID: 10846155
  38. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.
    J Virol. 1995 Nov;69(11):6609-17 PMID: 7474069
  39. Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning.
    J Mol Biol. 2004 Jan 2;335(1):209-19 PMID: 14659751
  40. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  41. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  42. Antibody neutralization and escape by HIV-1.
    Nature. 2003 Mar 20;422(6929):307-12 PMID: 12646921
  43. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.
    J Virol. 2005 Jul;79(14):8828-34 PMID: 15994776
  44. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
    Science. 2001 Aug 10;293(5532):1155-9 PMID: 11498595
  45. The molecular surface package.
    J Mol Graph. 1993 Jun;11(2):139-41 PMID: 8347567
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2007-02-15
Pages
732-7
Language
English
Region
England
NLM ID
0410462
PMCID
PMC2584968
Subset
IM
Grants
NIAID NIH HHS · U19 AI067854 · United States
NIAID NIH HHS · U19 AI067854-03 · United States
Intramural NIH HHS · United States
Databases
PDB
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com